Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterResearch Letter

Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus

Tiphaine Goulenok, Céline Mendes, Léa Dayan, Valentine Marie Ferre, Margot Bucau, Fatima Farhi, Thomas Papo and Karim Sacré
The Journal of Rheumatology December 2023, 50 (12) 1642-1644; DOI: https://doi.org/10.3899/jrheum.2022-1335
Tiphaine Goulenok
1Service de Médecine Interne, Hôpital Bichat, AP-HP;
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tiphaine Goulenok
Céline Mendes
1Service de Médecine Interne, Hôpital Bichat, AP-HP;
RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Léa Dayan
2Maison de santé pluriprofessionnelle Épinettes Grandes Carrières;
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentine Marie Ferre
3Service de Virologie, Hôpital Bichat, AP-HP;
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margot Bucau
4Service de Pathologie, Hôpital Bichat, AP-HP;
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Margot Bucau
Fatima Farhi
1Service de Médecine Interne, Hôpital Bichat, AP-HP;
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Papo
1Service de Médecine Interne, Hôpital Bichat, AP-HP;
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karim Sacré
1Service de Médecine Interne, Hôpital Bichat, AP-HP;
5Université Paris Cité, Centre de Recherche sur l’Inflammation, Inserm UMR1149, CNRS ERL8252, Faculté de Médecine site Bichat, Laboratoire d’Excellence Inflamex, Paris, France.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Karim Sacré
  • For correspondence: karim.sacre@aphp.fr
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

To the Editor:

Women with systemic lupus erythematosus (SLE), especially when exposed to immunosuppressive drugs, are at higher risk of human papillomavirus (HPV)-related cervical cancer.1 A recent study has shown that cervical cancer screening (CCS) coverage is worryingly low in this population.2 Our main objective was to determine whether a structured task force, which included healthcare professionals involved in the management and care of patients with SLE, might improve HPV-related CCS in this population.

Our study was conducted in the Internal Medicine Department of Hôpital Bichat, a national center for rare immune-mediated inflammatory diseases (Paris, France) by a team that included 1 SLE specialist, 1 general practitioner (GP) trained in gynecology and CCS, 1 clinical researcher associate, and 1 nurse. All SLE outpatients aged 20 to 65 years who had at least 1 visit in our department between September 2021 and July 2022 were screened. Patients were contacted to determine whether CCS was up to date according to the French national guidelines.3 CCS was considered up to date based on patient statement. Patients with inadequate CCS were asked to schedule CCS with the GP involved in the CCS team. All patients were given a questionnaire addressing sociodemographic characteristics, sexual and behavior risk factors, knowledge about CCS, and reasons for unperformed CCS. Data regarding SLE disease and treatment were extracted from electronic medical records using a standardized data collection form. All procedures were in accordance with local and national ethical standards. This human noninterventional study falls into the framework of MR-004 methodology, where approval from an institutional review board and written inform consent are not required according to the French Public Health laws. Nonetheless, patients were informed that their medical records might be used for research in accordance with the privacy rule. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki. Patients and/or the public were not involved in the design, conduct, reporting, or dissemination plans of this research.

According to the French recommendations,3 CCS should be performed regularly for all individuals with a cervix from age 25 until age 65. In our study, 167 patients with SLE aged 20 to 65 years were screened. Among them, 18 could not be reached to determine whether CCS was up to date and 12 had a prior hysterectomy (Supplementary Figure S1, available from the authors on request). Overall, the CCS status was investigated in 142 patients (median age 43.0 [IQR 36.2-50.0] yrs; Table). Only 4 (2.8%) patients were previously vaccinated against HPV. CCS was up to date in only 76 patients (53.5%), in whom HPV infection was detected in 12 cases and associated with cervical premalignant lesions in 8 (Supplementary Table S1, available from the authors on request). Among patients in whom CCS was not up to date (n = 66), 24 (36%) did not know that a GP—and not necessarily a gynecologist—could perform CCS. Further, 20 (30%) patients were unaware that CCS should be repeated over time, even though the first screening is negative. Patients avoided screening because CCS is unpleasant or painful (n = 19, 29%) or because they could not find a gynecologist in their neighborhood (n = 14, 21%). Low socioeconomic status and misunderstanding regarding CCS aims were associated with the “not up to date” status (Table). CCS was eventually performed in 31 of these 66 (47%) patients and led to the identification of HPV infection and cervical premalignant lesions in 10 and 4 cases, respectively (Supplementary Table S1, available from the authors on request). Overall, our program improved the rate of CCS from 53.5% (n = 76/142) to 75.4% (n = 107/142, P < 0.001; Supplementary Figure S1, available from the authors on request) and increased the number of detected HPV infection cases by a factor of 1.8 and the rate of HPV-associated premalignant lesions by a factor of 1.5.

View this table:
  • View inline
  • View popup
Table.

Characteristics of patients with SLE at baseline.

Despite national and international recommendations,1,3,4 CCS rate was low among patients with SLE entering our task force program; this is consistent with previous reports showing that only half of patients with SLE undergo CCS.1 The high prevalence of HPV infection—15.5% (n = 22/142) in our series—highlights the urgent need for increased awareness among rheumatologists regarding CCS.5 Importantly, our study (1) demonstrated that the direct implication of healthcare professionals involved in the management of patients with SLE results in a dramatic improvement in CCS coverage; (2) identified important patient-related factors associated with decreased odds of timely CCS; and (3) revealed a need for education on this topic not only in rheumatologists, GPs, and gynecologists but also in patients. In light of the 2022 American College of Rheumatology guidelines for vaccinations for patients with rheumatic and musculoskeletal diseases that now include a conditional recommendation for HPV vaccine,6 the HPV vaccination coverage—with girls aged 9 to 14 years before the start of sexual activity as a primary target—was very low in our SLE population.

Our study had several limitations. The sample size was low and the study design was monocentric. However, we believe that a similar approach may be easily implemented at other institutions as an effective way to improve HPV-based CCS in patients with SLE. These data underscore the crucial role of rheumatologists in CCS uptake. Efforts should be made to increase awareness of this issue among medical disciplines and SLE patient population.

ACKNOWLEDGMENT

We acknowledge Marie-Paule Chauveheid, Nicole Delory, Antoine Dossier, Chrystelle Francois, and Maureen Marie-Joseph from the Department of Internal Medicine Bichat Hospital; Clémentine Gonthier from the Department of Gynecology, Bichat Hospital; and Amélie Aim-Eusebi and Camille De Franceschi from the Maison de Santé Les Epinettes for their invaluable help.

Footnotes

  • This work was supported by the Université Paris Cité and by the AP-HP, Paris, France.

  • The authors declare no conflicts of interest relevant to this article.

  • Copyright © 2023 by the Journal of Rheumatology

REFERENCES

  1. 1.↵
    1. Andreoli L,
    2. Bertsias GK,
    3. Agmon-Levin N, et al.
    EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 2017;76:476-85.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Chung SH,
    2. Oshima K,
    3. Singleton M, et al.
    Determinants of cervical cancer screening patterns among women with systemic lupus erythematosus. J Rheumatol 2022;49:1236-41.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Haute Autorité de Santé
    . Evaluation of human papillomavirus (HPV) tests for primary screening of precancerous and cancerous lesions of the cervix and the role of p16/Ki67 dual immunostaining. Public health guidelines summary; 2019. [Internet. Accessed May 15, 2023.] Available from: https://www.has-sante.fr/upload/docs/application/pdf/2019-09/synthese_anglais_hpv.pdf
  4. 4.↵
    1. Moscicki AB,
    2. Flowers L,
    3. Huchko MJ, et al.
    Guidelines for cervical cancer screening in immunosuppressed women without HIV infection. J Low Genit Tract Dis 2019;23:87-101.
    OpenUrlCrossRef
  5. 5.↵
    1. Zard E,
    2. Arnaud L,
    3. Mathian A, et al.
    Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: A meta-analysis of the literature. Autoimmun Rev 2014;13:730-5.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Bass AR,
    2. Chakravarty E,
    3. Akl EA, et al.
    2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Rheumatol 2023;75:333-48.
    OpenUrl
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 50, Issue 12
1 Dec 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus
Tiphaine Goulenok, Céline Mendes, Léa Dayan, Valentine Marie Ferre, Margot Bucau, Fatima Farhi, Thomas Papo, Karim Sacré
The Journal of Rheumatology Dec 2023, 50 (12) 1642-1644; DOI: 10.3899/jrheum.2022-1335

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus
Tiphaine Goulenok, Céline Mendes, Léa Dayan, Valentine Marie Ferre, Margot Bucau, Fatima Farhi, Thomas Papo, Karim Sacré
The Journal of Rheumatology Dec 2023, 50 (12) 1642-1644; DOI: 10.3899/jrheum.2022-1335
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • ACKNOWLEDGMENT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Advancing Knowledge and Care for Axial Spondyloarthritis in Latin America Through a Unified Database: The ESPALDA Registry
  • How Should We Count the Toe Joints in the 66/68 Joint Count in Psoriatic Arthritis? Results of an International Survey
  • Varicella Zoster Virus Vaccination in Patients With Immune-Mediated Inflammatory Diseases: Drivers and Barriers
Show more Research Letter

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire